BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 21642874)

  • 41. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
    Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Zhang PL; Xu XQ
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.
    Li X; Zhang H; Xing L; Ma H; Xie P; Zhang L; Xu X; Yue J; Sun X; Hu X; Chen M; Xu W; Chen L; Yu J
    Radiother Oncol; 2012 Feb; 102(2):246-50. PubMed ID: 22100657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.
    Shen G; Lan Y; Zhang K; Ren P; Jia Z
    PLoS One; 2017; 12(3):e0173104. PubMed ID: 28253364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiographic staging of mediastinal lymph nodes in non-small cell lung cancer patients.
    Groth SS; Whitson BA; Maddaus MA
    Thorac Surg Clin; 2008 Nov; 18(4):349-61. PubMed ID: 19086605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.
    Dwamena BA; Sonnad SS; Angobaldo JO; Wahl RL
    Radiology; 1999 Nov; 213(2):530-6. PubMed ID: 10551237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer.
    Pozo-Rodríguez F; Martín de Nicolás JL; Sánchez-Nistal MA; Maldonado A; García de Barajas S; Calero-García R; Pozo MA; Martín-Escribano P; Martín-García I; García-Lujan R; Lopez-Encuentra A; Arenas de Pablo A
    J Clin Oncol; 2005 Nov; 23(33):8348-56. PubMed ID: 16219937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
    Tournoy KG; Maddens S; Gosselin R; Van Maele G; van Meerbeeck JP; Kelles A
    Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients].
    Liu LP; Yu JM; Guo HB; Fu Z; Han AQ; Yang GR
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):453-6. PubMed ID: 17974282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
    De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
    J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancer.
    Shingyoji M; Nakajima T; Yoshino M; Yoshida Y; Ashinuma H; Itakura M; Tatsumi K; Iizasa T
    Ann Thorac Surg; 2014 Nov; 98(5):1762-7. PubMed ID: 25149044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Assessment of Occult Lymph Node Metastasis in Non-Small Cell Lung Cancer.
    Seol HY; Kim YS; Kim SJ
    Oncology; 2021; 99(2):96-104. PubMed ID: 32980838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation between PET/CT findings and pathological features of mediastinal lymph nodes in non-small cell lung cancer.
    Li X; Zheng X; Cao Y; Wang Y; Fan X; Xu W
    Minerva Med; 2022 Jun; 113(3):586-588. PubMed ID: 33881280
    [No Abstract]   [Full Text] [Related]  

  • 53. Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer.
    von Haag DW; Follette DM; Roberts PF; Shelton D; Segel LD; Taylor TM
    J Surg Res; 2002 Apr; 103(2):160-4. PubMed ID: 11922730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition).
    Silvestri GA; Gould MK; Margolis ML; Tanoue LT; McCrory D; Toloza E; Detterbeck F;
    Chest; 2007 Sep; 132(3 Suppl):178S-201S. PubMed ID: 17873168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mediastinal lymph node staging by means of positron emission tomography is less sensitive in elderly patients with non-small-cell lung cancer.
    Al-Sarraf N; Gately K; Lucey J; Wilson L; McGovern E; Young V
    Clin Lung Cancer; 2008 Jan; 9(1):39-43. PubMed ID: 18282357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
    Hellwig D; Graeter TP; Ukena D; Groeschel A; Sybrecht GW; Schaefers HJ; Kirsch CM
    J Nucl Med; 2007 Nov; 48(11):1761-6. PubMed ID: 17942814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.
    Vansteenkiste JF; Stroobants SG; De Leyn PR; Dupont PJ; Bogaert J; Maes A; Deneffe GJ; Nackaerts KL; Verschakelen JA; Lerut TE; Mortelmans LA; Demedts MG
    J Clin Oncol; 1998 Jun; 16(6):2142-9. PubMed ID: 9626214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis.
    de Langen AJ; Raijmakers P; Riphagen I; Paul MA; Hoekstra OS
    Eur J Cardiothorac Surg; 2006 Jan; 29(1):26-9. PubMed ID: 16337397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
    Kuo WH; Wu YC; Wu CY; Ho KC; Chiu PH; Wang CW; Chang CJ; Yu CT; Yen TC; Lin C
    Acad Radiol; 2012 Jun; 19(6):685-92. PubMed ID: 22459646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic potential of [
    Zhang M; Yang W; Yuan Y; Liu Z; Yue X; Cao X; Han B
    Jpn J Radiol; 2024 Jan; 42(1):87-95. PubMed ID: 37566187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.